Propafenone is a prescription heart rhythm medication used to prevent episodes of certain irregular heartbeats, specifically atrial fibrillation, atrial flutter, and supraventricular tachycardia. It also treats life-threatening ventricular arrhythmias. The drug belongs to a group called Class IC antiarrhythmics, which work by slowing electrical signals in the heart to help it beat in a normal, steady pattern.
FDA-Approved Uses
Propafenone has three approved indications, all centered on keeping abnormal heart rhythms from coming back or controlling dangerous ones that are already present.
The most common use is for paroxysmal atrial fibrillation or atrial flutter. “Paroxysmal” means the episodes start and stop on their own rather than being constant. In this setting, propafenone extends the time between episodes in people whose symptoms are disabling, such as intense palpitations, shortness of breath, or lightheadedness. It is only approved for people without structural heart disease, meaning the heart’s valves, walls, and muscle are otherwise normal.
The second approved use is for paroxysmal supraventricular tachycardia (PSVT), a rapid heartbeat that originates above the lower chambers of the heart. Again, the goal is to keep episodes from recurring, and the same requirement applies: no underlying structural heart problems.
The third use is for documented, life-threatening ventricular arrhythmias like sustained ventricular tachycardia, where the lower chambers of the heart beat dangerously fast. Because of the severity of this condition, treatment is started in a hospital under monitoring.
The “Pill-in-the-Pocket” Approach
Beyond daily use, propafenone plays a well-known role as a rescue medication for atrial fibrillation episodes. In this strategy, you carry the medication with you and take a single dose only when an episode begins, rather than taking pills every day. The standard single rescue dose is 600 mg, or 450 mg for people weighing under about 155 pounds (70 kg).
This approach isn’t something you start on your own. Current guidelines recommend that the first dose be given in a monitored medical setting to confirm it’s safe for you before you use it at home. Screening typically includes an echocardiogram to rule out structural heart disease, and for men over 40 and women over 50, periodic stress testing to check for coronary artery disease. Once safety is confirmed, many people find this approach convenient because it avoids the side effects of daily medication while still giving them a reliable way to stop an episode.
Why Structural Heart Disease Matters
The restriction to patients without structural heart disease isn’t arbitrary. It comes from a landmark trial called CAST, run by the National Heart, Lung, and Blood Institute. That trial tested Class IC antiarrhythmics in people who had survived a heart attack and found that the drugs more than doubled the rate of death or cardiac arrest compared to placebo: 7.7% versus 3.0% over an average treatment period of 10 months. Although the trial tested two related drugs (encainide and flecainide) rather than propafenone itself, all Class IC medications are now considered to carry a significant risk of actually worsening heart rhythms in people with structural heart disease.
Among patients who did experience worsening of ventricular tachycardia while taking propafenone in clinical studies, 71% had coronary artery disease and 68% had a prior heart attack. This is why your doctor will want a clear picture of your heart’s structure and blood supply before prescribing it.
How Propafenone Works in the Body
Propafenone comes in two forms: immediate-release tablets taken two or three times a day, and extended-release capsules taken twice daily. With the extended-release version, blood levels peak somewhere between three and eight hours after a dose.
One important quirk of propafenone is that your genetics play a large role in how quickly your body breaks it down. The drug is processed primarily by a liver enzyme called CYP2D6, and roughly 7 to 10% of people of European descent are “poor metabolizers,” meaning their version of this enzyme works slowly. In poor metabolizers, the drug’s half-life (the time it takes for half the drug to leave your bloodstream) averages about 12.8 hours. In normal metabolizers, that number drops to roughly 2.7 hours, nearly a fivefold difference. This means the same dose can produce much higher, longer-lasting blood levels in some people, which affects both effectiveness and the likelihood of side effects.
Common Side Effects
The most frequently reported side effect is an unusual or metallic taste in the mouth. Many people notice it within the first days of treatment, and it can persist as long as they take the medication. It’s not harmful, but it can be annoying enough to affect appetite or enjoyment of food.
Less common side effects include dizziness and nausea or vomiting. Because the drug slows electrical conduction in the heart, it can also cause new or worsened rhythm disturbances in a small percentage of people, which is one reason initial doses for serious arrhythmias are given under medical supervision.
Drug Interactions to Know About
Because propafenone depends so heavily on liver enzymes for processing, other medications that affect those same enzymes can change how much propafenone stays active in your body. Fluoxetine (a common antidepressant) inhibits the same CYP2D6 enzyme that breaks down propafenone, which can raise propafenone levels significantly. Rifampin, an antibiotic used for tuberculosis and certain other infections, speeds up propafenone’s breakdown and can make it less effective. Interactions with other heart rhythm drugs like lidocaine and mexiletine have also been documented. If you’re starting or stopping any medication while on propafenone, your prescriber will want to review potential interactions carefully.